Feds Extend Immunity To Ex-Retrophin Exec Over Hacking Claim

By Jack Newsham · November 14, 2017, 8:57 PM EST

A former executive at Martin Shkreli's drug company Retrophin Inc. struck a nonprosecution agreement with Brooklyn federal prosecutors on Tuesday and continued testifying after lawyers for accused securities fraud co-conspirator and ex-BigLaw...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

USA v. Shkreli et al

Case Number

Court

New York Eastern

Nature of Suit

Date Filed

December 14, 2015

Recent Articles By Jack

February 14, 2019
Subsys-Prescribing Doc Cops To Kickback Conspiracy
December 10, 2018
Judge Mulls Several Outcomes For NY Opioid Surcharge Law
November 13, 2018
Ex-CEO Accused Of Tipping Oriole Reaches $1.5M SEC Deal
August 24, 2018
Ex-CDC Head Thomas Frieden Arrested On Sex Crime Charges
June 04, 2018
Filmmaker Takes 2nd Crack At Theranos Deposition Footage
June 01, 2018
Shkreli Deals Saved Retrophin Millions, Ex-Katten Atty Argues
May 23, 2018
CORRECTED: Convictions Don't Mean Valeant Is Off The Hook
May 22, 2018
Express Scripts Beats Investor Suit Over Anthem Disclosures
May 22, 2018
Ex-Manager, CEO Convicted In $9.7M Valeant Kickback Plot
May 17, 2018
$9.7M Valeant Payment Was Legal, Ex-Execs Argue In Closing